1887
Rapid communication Open Access
Like 0

Abstract

We report the timely detection of a strain of which was confirmed as a diagnostic escape mutant on the Cepheid Xpert CT/NG assay in England in June 2025. The reason for assay failure was a likely recombination event with , which removed both assay target sites. Seven historical putative Xpert CT/NG assay diagnostic escape mutants were also identified following subsequent in silico screening of gonococcal genome collections, but currently there is no evidence of widespread circulation.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.36.2500673
2025-09-11
2026-04-11
/content/10.2807/1560-7917.ES.2025.30.36.2500673
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/36/eurosurv-30-36-1.html?itemId=/content/10.2807/1560-7917.ES.2025.30.36.2500673&mimeType=html&fmt=ahah

References

  1. Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, et al. Performance of the Cepheid CT/NG Xpert Rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013;51(6):1666-72.  https://doi.org/10.1128/JCM.03461-12  PMID: 23467600 
  2. Rotman E, Seifert HS. The genetics of Neisseria species. Annu Rev Genet. 2014;48(1):405-31.  https://doi.org/10.1146/annurev-genet-120213-092007  PMID: 25251852 
  3. UK Health Security Agency (UKHSA). UK Standards for Microbiology Investigations. V 37: Chlamydia and Gonorrhoea infection – testing by Nucleic Acid Amplification Tests (NAATs). London: UKHSA; 2024. Available from: https://www.rcpath.org/static/9173ccae-7d23-4eb9-b8eaf50c05b3889e/UK-SMI-V-37i5-Chlamydia-and-Gonorrhoea-infection-testing-by-Nucleic-Acid-Amplification-Tests-December-2024.pdf
  4. Jacobsson S, Boiko I, Golparian D, Blondeel K, Kiarie J, Toskin I, et al. WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances. APMIS. 2018;126(12):907-12.  https://doi.org/10.1111/apm.12902  PMID: 30456870 
  5. Tabrizi SN, Unemo M, Golparian D, Twin J, Limnios AE, Lahra M, et al. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol. 2013;51(6):1945-7.  https://doi.org/10.1128/JCM.00806-13  PMID: 23554203 
  6. Fifer H, Doumith M, Rubinstein L, Mitchell L, Wallis M, Singh S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis. J Antimicrob Chemother. 2024;79(12):3332-9.  https://doi.org/10.1093/jac/dkae369  PMID: 39417254 
  7. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20(1):257.  https://doi.org/10.1186/s13059-019-1891-0  PMID: 31779668 
  8. Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes De Novo Assembler. Curr Protoc Bioinformatics. 2020;70(1):e102.  https://doi.org/10.1002/cpbi.102  PMID: 32559359 
  9. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403-10.  https://doi.org/10.1016/S0022-2836(05)80360-2  PMID: 2231712 
  10. Alfhous W, Persing D, Higuchi R, Wang J, Vanatta R, Murray WE. inventors; Cepheid, assignee. Methods of detecting chlamydia and gonorrhea and of screening for infection/inflammation based on genomic copy number patent WO 2013/177329 A1. 2013. Available from: https://patents.justia.com/patent/20150376683
  11. Sun S, Narayanan P, Vickers A, Pitt R, Doumith MD, David S, et al. GRASP report: data to August 2024. London; 2024. Available from: https://www.gov.uk/government/publications/gonococcal-resistance-to-antimicrobials-surveillance-programme-grasp-report/grasp-report-data-to-august-2024
  12. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124.  https://doi.org/10.12688/wellcomeopenres.14826.1  PMID: 30345391 
  13. Fifer H, Ismail MA, Soni S, Nwaosu U, Sadiq ST, Milligan A, et al. British Association of Sexual Health and HIV UK National Guideline for the Management of infection with Neisseria gonorrhoeae, 2025. Int J STD AIDS. 2025;0(0).  https://doi.org/10.1177/09564624251345195  PMID: 40448704 
  14. UK Health Security Agency (UKHSA). National STI surveillance data 2024: Table 4. London: UKHSA; 2025. Available from: https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables
  15. Town K, Harris S, Sánchez-Busó L, Cole MJ, Pitt R, Fifer H, et al. Genomic and Phenotypic Variability in Neisseria gonorrhoeae Antimicrobial Susceptibility, England. Emerg Infect Dis. 2020;26(3):505-15.  https://doi.org/10.3201/eid2603.190732  PMID: 32091356 
  16. Golparian D, Cole MJ, Sánchez-Busó L, Day M, Jacobsson S, Uthayakumaran T, et al. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study. Lancet Microbe. 2024;5(5):e478-88.  https://doi.org/10.1016/S2666-5247(23)00370-1  PMID: 38614111 
  17. Carver TJ, Rutherford KM, Berriman M, Rajandream MA, Barrell BG, Parkhill J. ACT: the Artemis Comparison Tool. Bioinformatics. 2005;21(16):3422-3.  https://doi.org/10.1093/bioinformatics/bti553  PMID: 15976072 
/content/10.2807/1560-7917.ES.2025.30.36.2500673
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error